Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Case Report
Editorial
Letter to Editor
Letter to the Editor
Mini Review
Original Article
Original Articles
Point of View
Review
Review Article
Short communication
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Case Report
Editorial
Letter to Editor
Letter to the Editor
Mini Review
Original Article
Original Articles
Point of View
Review
Review Article
Short communication
View/Download PDF

Translate this page into:

Original Article
6 (
1
); 9-17
doi:
10.7324/jhsr.2021.612

Anti-Toxoplasma gondii Antibodies: Prevalence and Risk Factors among Pregnant Women Accessing Antenatal Care in Some Primary Health Centers in Jos Metropolis, Nigeria

Department of Microbiology, Faculty of Natural Sciences, University of Jos, Plateau State, Nigeria
Department of Pharmaceutical Microbiology, Faculty of Pharmaceutical Sciences, University of Jos, Plateau State, Nigeria
Department of Zoology, Faculty of Natural and Applied Sciences, Nasarawa State University, Keffi, Nasarawa State, Nigeria
Department of Microbiology, Faculty of Life Sciences, Ahmadu Bello University, Zaria, Nigeria
Department of Microbiology, Federal University Dutsin-Ma, Katsina State, Nigeria
Email: okojokwuoj@gmail.com
Licence
This open access article is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). http://creativecommons.org/licenses/by/4.0

How to cite this article: Okojokwu OJ, Onaji IA, Entonu EE, Abubakar BS, Adebayo MB, Adamu NA, Ejembi DI, Yusuf IA, Ogaji AO, Ali MA, Anejo-Okopi JA. Anti-Toxoplasma gondii Antibodies: Prevalence and Risk Factors among Pregnant Women Accessing Antenatal Care in Some Primary Health Centers in Jos Metropolis, Nigeria. J Health Sci Res 2021;6(1):9-17.

Abstract

Toxoplasma gondii infection causes a high rate of gestational and congenital infection across the globe and is considered a both a public health problem and a neglected disease. The study was carried out to determine the prevalence of anti-T. gondii antibodies and the associated risk factors among pregnant women attending antenatal care in some Primary Health Centers in Jos, Plateau State, Nigeria. In this cross-sectional study carried out within 5 months between January and May 2019, a total of 182 blood samples were collected from consenting pregnant women. Structured questionnaire was used to obtain data on sociodemography and risk factors. Three milliliters of blood samples were collected from the study participants. Sera were separated from the blood and evaluated for anti-T. gondii antibodies (IgG and IgM) using enzyme-linked immunosorbent assay. The data collected from the experiment were analyzed using Statistical Package for the Social Sciences. Out of the 182 samples examined, 84 (46.2%) had anti-T. gondii IgG antibody and 2 (1.1%) had IgM antibody, while 98 (53.4%) were neither seropositive for IgG nor IgM. Trimester of pregnancy was significantly associated with prevalence of anti-Toxoplasma IgM antibody. In conclusion, toxoplasmosis is prevalent in Jos. Eleven out of every 1000 women (i.e., 1.1%) had recent toxoplasmosis and 53.4% were not protected against primary infection, thereby underscoring the need for prevention and control during pregnancy through enlightenment.

Keywords

Jos-Nigeria
Pregnant Women
Seroprevalence
Toxoplasma gondii
Toxoplasmosis

Introduction

Toxoplasma gondii, which occurs worldwide, is an obligate intracellular apicomplexan protozoan parasite that is responsible for toxoplasmosis in animals and humans1,2. It is estimated that over one-third of the world human population is infected, with reported incidence rate of congenital toxoplasmosis ranging from 400 to 4000 cases per year3,4. The parasite is implicated for 1.2 million disability-adjusted life years annually5.

The main transmission pathway of T. gondii includes vertical transmission (from pregnant mother to fetus), eating raw or undercooked meat, and consumption of vegetables, water, and foods contaminated with oocysts of the parasites6. Should primary infection occurs during pregnancy, the parasite could cross the placental barrier causing congenital toxoplasmosis, which may lead to myriad of health problems such as spontaneous miscarriage, stillbirth, or congenital abnormalities such as mental retardation, hydrocephalus, intracerebral calcifications, and chorioretinitis7-11. Awoke et al.9 reported that antenatal screening of pregnant women for T. gondii infection is based on IgG and IgM antibodies detection and is the main means of monitoring the risk for congenital toxoplasmosis.

The danger of congenital toxoplasma infection and the seriousness of fetal harm are reliant on the gestational age when the maternal infection takes place12. The general danger of congenital maternal infection from primary toxoplasmosis during pregnancy varies from 20% to 50% if left untreated13. Prevention of congenital toxoplasmosis can be achieved by identifying non-immunized women at the onset of pregnancy and enlighten them on how to prevent the infection, and by serological follow-up. Multiple testing for Toxoplasma-specific IgG and IgM helps to differentiate between acute and chronic infections12.

Prevalence of congenital toxoplasmosis across the globe vary between 4.3 and 75.0% in Africa14-17, 6.8–51.8% in Europe18-20, 14.0–96.3% in Asia21-23, 10.6–13.0% in North America,24-26 and 26.3–80.0% in South America27-29.

Despite the risk of vertical transmission of toxoplasmosis, serological tests for T. gondii infection are not routinely performed during pregnancy in Nigeria. Hence, prevalence and the burden of toxoplasmosis are poorly understood. The aim of this study, therefore, was to investigate the seroprevalence and risk factors of T. gondii infection by determining (1) the seroprevalence of IgG and IgM specific to T. gondii and (2) risk factors that are associated with toxoplasmosis.

Material and Methods

Study area and population

This cross-sectional study was carried out from January to May 2019 in Jos, located between latitude 9°55’42.56’’N and longitude 8°53’31.63’’E, among women attending antenatal care at some Primary Health Centers (PHC) in Jos, Plateau State Nigeria.

Ethical considerations

Ethical clearance was obtained from the Ethical Review Committee of the Plateau State Specialist Hospital, Jos, Nigeria, under the number NHREC/O5/01/2010b. A signed informed consent form was obtained from each study subject at the beginning of the study. Confidentiality of patient information and samples was ensured and maintained at all times. Spent samples were appropriately autoclaved and disposed after usage.

Collection of blood sample and sociodemographic data

This research was a cross-sectional study and it was carried out within 5 months. Samples were collected from pregnant women accessing antenatal care at some (PHC Dogo Agogo, PHC Jos Township, and PHC Jos Jarawa), Jos. Information on sociodemographic as well as some risk factors of T. gondii infection was collected using a structured questionnaire.

Approximately 3 ml blood samples were aspirated from each patient and coded. The samples were kept at ambient temperature to clot and were thereafter spun at 1000 g for 10 min. The sera were collected in 2-ml Eppendorf tubes and taken to Plateau State Human Virology Research Centre in an icebox where the samples were kept at −20°C until analysis30.

Serological testing

Testing for anti-T. gondii antibodies (IgM and IgG) were done with enzyme-linked immunosorbent assay (ELISA kit provided by Diagnostic Automation, INC USA). The kits were used following the manufacturer’s instructions and guidelines.

Statistical analysis of data

Data from this study were saved on Excel® spreadsheet and analyzed using Statistical Package for the Social Science version 23. Chi-square test was used to determine the relationships between the risk factors and seropositivity. P ≤0.05 was considered statistically significant.

Results

Overall, 182 subjects were included in this study; 84 (46.2%) had anti-Toxoplasma IgG antibody, while 2 (1.1%) were positive for IgM antibody. Two study subjects that had IgM antibody were also seropositive for anti-Toxoplasma IgG antibody representing 2.4% (2/84) of the women who were seropositive for anti-Toxoplasma IgG. Ninety-eight (98 [53.4%]) of the subjects were seronegative for both anti-Toxoplasma IgG and IgM antibodies (Figure 1).

Figure 1.
Relationship between Anti-Toxoplasma antibodies (IgG and IgM) status of the study subjects.

Although the demographic parameters show no association (P > 0.05) with the prevalence of anti-Toxoplasma antibodies, the age group 11–20 years had the highest prevalence of IgG antibody, while women within the age group 41–50 years had 0.0% prevalence of IgG antibody to T. gondii. On the other hand, all the 2 subjects that tested positive to IgM antibody were in the age bracket of 31–40 years. With respect to educational status, the seroprevalence anti-Toxoplasma IgG antibody decreased from 100% in women without formal education to 40.0% in women with tertiary level of education. The two women who were seropositive for IgM antibody had secondary level of education (Table 1). In terms of occupation of the pregnant women, majority of the women were unemployed (53.8%), while 46.2% of them were employed. The highest prevalence (66.7%) of IgG antibody was detected among students, while the least (44.2%) was detected among housewives. In similar vein, the housewives 2.3% prevalence of IgM antibody (Figure 2).

Table 1. Prevalence of Anti -Toxoplasma gondii antibodies with respect to demographics
Parameter Number examined (%) IgG positive (%) IgM positive (%)
Age group (years)
11–20 38 (20.9) 24 (63.2) 0 (0.0)
21–30 110 (60.6) 46 (41.8) 0 (0.0)
31–40 32 (39.0) 14 (43.8) 2 (6.3)
41–50 2 (1.1) 0 (0.0) 0 (0.0)
Total 182 (100.0) 84 (46.2) 2 (1.1)
χ2 3.521 4.740
P-value 0.318 0.192
Educational status
No formal education 2 (1.1) 2 (100.0) 0 (0.0)
Primary 30 (16.5) 14 (46.7) 0 (0.0)
Secondary 130 (71.4) 60 (46.2) 2 (1.5)
Tertiary 20 (11.0) 8 (40.0) 0 (0.0)
Total 182 (100.0) 84 (46.2) 2 (1.1)
χ2 1.321 0.404
P-value 0.724 0.939
Statistically significant at P≤0.001, *Statistically significant at P≤0.005

There was statistically significant association (χ2 = 14.324; P = 0.001) between trimester and prevalence of anti-Toxoplasma IgM antibody. None of all the other risk factors studied in the present research had association (P > 0.05) with anti-Toxoplasma antibodies (Table 2).

Table 2. Prevalence of anti -Toxoplasma gondii antibodies in relation to risk factors
Parameter Number examined (%) IgG positive (%) IgM positive (%)
Trimester
First 12 (6.6) 8 (66.7) 2 (16.7)
Second 98 (53.8) 40 (40.8) 0 (0.0)
Third 72 (39.6) 36 (50.0) 0 (0.0)
Total 182 (100.0) 84 (46.2) 2 (1.1)
χ2 1.792 14.324
P-value 0.408 0.001**
HIV status
Positive 82 (45.1) 34 (41.5) 2 (2.4)
Negative 98 (53.8) 48 (49.0) 0 (0.0)
No idea 2 (1.1) 2 (100.0) 0 (0.0)
Total 182 (100.0) 84 (46.2) 2 (1.1)
χ2 1.687 1.233
P-value 0.430 0.540
Source of water
Well 22 (12.1) 10 (45.5) 0 (0.0)
Tap 116 (63.7) 56 (48.3) 2 (1.7)
Bore-hole 44 (24.2) 18 (40.9) 0 (0.0)
Total 182 (100.0) 84 (46.2) 2 (1.1)
χ2 0.351 0.575
P-value 0.839 0.750
No 100 (54.9) 46 (46.0) 2 (2.0)
Total 182 (100.0) 84 (46.2) 2 (1.1)
χ2 0.001
P-value 0.974 1.000
Do you have contact with cat?
Yes 32 (17.6) 12 (37.5) 0 (0.0)
No 150 (82.4) 72 (48.0) 2 (1.3)
Total 182 (100.0) 84 (46.2) 2 (1.1)
χ2 0.585
P-value 0.444 1.000†
Statistically significant at P≤0.001; *Statistically significant at P≤0.005; Fisher’s exact test.
Figure 2.
Prevalence of anti-Toxoplasma antibodies based on employment status (IgG: χ2 = 1.137; P = 0.768 and IgM: χ2 = 1.129; P = 0.770).

Discussion

The present study is among the few works in Nigeria that explore the seroprevalence of T. gondii infection in pregnant women and to determine the risk factors associated with the infection in this cohort. Toxoplasmosis is a treatable though likely fatal disease. The problem with most communities with substantial prevalence of T. gondii infection is the long-term complications which follows congenital infections and the ability to cause opportunistic infections that are life-threatening in immunocompromised or immunosuppressed individuals3,31.

Our findings showed that the seroprevalence of anti-T. gondii antibodies in women visiting antenatal clinic in PHC in Jos was 46.2% and 1.1% for IgG and IgM, respectively. This implies that 46.2% of the study subjects had been exposed and possibly recovered from the infection, while 1.1% of the women have ongoing or current Toxoplasma infection. Hence, the finding suggests that the parasitic infection is endemic in the study area. The anti-T. gondii IgG prevalence reported that in the current study was higher than previously reported ones for Sudan (41.7%), Somalia (29.6%), and Algeria (52.2%)32. When compared with findings from other parts of Nigeria, the seroprevalence was higher than the 32.6% and 40.6% reported by Deji-Agboola33 and Akinbami et al.34 in Lagos and 29.1% obtained among pregnant women in Zaria35. These various findings lend credence to the fact that Toxoplasma infection varies significantly within and between countries5,36-39. The difference in the seroprevalence of T. gondii infection could be attributed to the variation in geographic locations of the study areas as manifested in differences in humidity and temperature. Higher temperatures and/or humid environments favor sporulation of oocysts40,41. Furthermore, the variation in prevalence of T. gondii infection could be partly due to the use of different analytic techniques such as the use of ELISA versus rapid diagnostic tool and/or polymerase chain reaction. This is because these analytic techniques have different rates of sensitivity and specificity42. In addition, difference in socioeconomic status of the women and variation in samples could have impacted on prevalence reported in the various findings, thus bringing about the discrepancies in the reported figures.

The correlation between sociodemographic characteristics of the pregnant women and prevalence of anti-T. gondii antibodies were assessed in the current study. In concordance with findings from other authors43,44, there was no significant association between Toxoplasma seroprevalence and increasing maternal age, but younger women (21–30 years) were found to have a relatively higher seroprevalence rate compared to older women (>30 years). This might be explained by younger rather than older women’s preference for outings overeating at home. During those outings, the women are exposed to grilled meat which might be undercooked. Fruits and salads which may be contaminated with the parasite oocysts are also often eaten in such outings hence increasing the risk of infections45-47. Prevalence of anti-T. gondii antibody (IgG) in this study decreased with increasing educational level. This finding was in accordance with the study done in Debre Tabor, Northwest Ethiopia, where pregnant women who could neither read nor write had the highest toxoplasmosis infection rate compared with those with primary, secondary, and tertiary levels of education48,49. Illiterate women are more likely to engage in more risky unsanitary and unhygienic practices hence are more liable to be infected by T. gondii. Though significant association was not observed between prevalence of anti-Toxoplasma gondii antibodies and both occupation and educational level, the prevalence increases with decrease in educational level. This is in concordance with reported findings from Africa50-52.

However, there was a significant relationship between trimester of pregnancy and prevalence of anti-T. gondii IgM antibody. Women in the first trimester of pregnancy had the highest prevalence of Toxoplasma infection. Although the gravidity of the women was not established in this study, Mandour et al.53 reported an increased percentage of multigravid women, in whom complicated pregnancy outcomes have been reported compared with primigravid females. In view of that finding, it is likely that the majority of the women in the first trimester of their pregnancy were multigravid females.

Our findings showed no association between T. gondii infection and contact with cats. This suggests that contact with cats does not translate to zoonosis, but more pertinent in causing zoonosis is the improper handling of cats’ fecal matter54. While this finding disagrees with the reports of Lim et al.55 and Adeniyi et al.,56 where they showed a significant association between contact with cats and seroprevalence of T. gondii infection, it is consistent with the findings of Doehring et al.57, Nijem and Al-Amleh,40 and Wang et al.58. It was also found that though immune-compromised individuals were reported to be more prone to toxoplasmosis59, HIV-negative women had a higher prevalence of the infection in comparison with HIV-positive pregnant counterparts. It is likely that the use of antiretroviral therapy by HIV-positive women reduced the probability of opportunistic infections.

Two pregnant women with active/ongoing toxoplasmosis were detected. This implies that their fetuses were at risk of congenital T. gondii infection with attendant adverse and sometime fatal consequences. The presence of active cases of toxoplasmosis in this study, therefore, underscores the need and importance of screening of pregnant women to control congenital transmission of toxoplasmosis and its unfavorable birth outcomes such as miscarriages, hydrocephalus, cerebral calcification, poor cognitive development, and fetal death59.

Conclusion and Recommendation

This study confirms prevalence of T. gondii infection among pregnant women accessing antenatal care in Jos metropolis, Plateau State, Nigeria. None of the risk factors studied with respect to IgG antibody was associated with toxoplasmosis. In spite of the absence of a significant association between possible risk factors and the infection, there is a need for the enlightenment of women, particularly pregnant women, on the risk factors and how to prevent the contraction of toxoplasmosis.

Authors’ Contributions

OJO: Conceptualization, investigation, methodology, validation, writing original draft manuscript/review and editing. IAO: Data curation, formal analysis, review and editing of final manuscript. EEE: Supervision, validation, review and editing of final manuscript. BSA: Data curation, investigation, methodology, validation. MBA: Formal analysis, investigation, methodology, writing of original draft manuscript/review, and editing. NAA: Data curation, investigation, methodology. IAY: Data curation, investigation, methodology, validation. AOO: Data curation, methodology, resources. MAA: Data curation, investigation, review and editing of final manuscript. JAA: Formal analysis, investigation, methodology, writing of original draft manuscript/review and editing. All the authors approved the final manuscript before submission.

Conflicts of Interest

The authors declare that there are no conflicts of interest regarding the publication of this article.

References

  1. , , , , . Sero-prevalence of latent Toxoplasma gondii infection among HIV infected and HIV-uninfected people in Addis Ababa, Ethiopia: A comparative cross-sectional study. BMC Res Notes. 2009;2:213.
    [CrossRef] [PubMed] [Google Scholar]
  2. , . The global burden of congenital Toxoplasmosis: A systematic review. Bull World Health Organ. 2013;91(7):501-8.
    [PubMed] [Google Scholar]
  3. , , . Seroprevalence of Toxoplasma gondii in Nazareth town, Ethiopia. East Afr J Public Health. 2008;5(3):211-4.
    [CrossRef] [PubMed] [Google Scholar]
  4. , , , , , , et al. Unusual manifestation of cutaneous toxoplasmosis in a HIV positive patient. Trop Biomed. 2010;27(3):447-50.
    [PubMed] [Google Scholar]
  5. , . The global burden of congenital toxoplasmosis: A systematic review. Bull World Health Organ. 2013;91(7):501-8.
    [CrossRef] [PubMed] [Google Scholar]
  6. , , , , , . Toxoplasma gondii Epidemiology, feline clinical aspects, and prevention. Trends Parasitol. 2010;26(4):190-6.
    [CrossRef] [PubMed] [Google Scholar]
  7. , , . Toxoplasma gondii From animals to humans. Int J Parasitol. 2000;30(12-13):1217-58.
    [CrossRef] [PubMed] [Google Scholar]
  8. . Toxoplasmosis: Beyond animals to humans. Trends Parasitol. 2006;22(3):137-42.
    [PubMed] [Google Scholar]
  9. , , . Sero-prevalence and associated risk factors of Toxoplasma gondii infection among pregnant women attending antenatal care at Felege Hiwot Referral Hospital, Northwest Ethiopia. Asian Pac J Trop Med. 2015;8(7):549-54.
    [CrossRef] [PubMed] [Google Scholar]
  10. , . Congenital toxoplasmosis: An overview of the neurological and ocular manifestations. Parasitol Int. 2018;67(6):715-21.
    [CrossRef] [PubMed] [Google Scholar]
  11. , , , . Toxoplasma gondii in women of childbearing age and during pregnancy: Seroprevalence study in Central and Southern Italy from 2013 to 2017. Parasite. 2020;27:2.
    [CrossRef] [PubMed] [Google Scholar]
  12. , . Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev. 2012;25(2):264-96.
    [CrossRef] [PubMed] [Google Scholar]
  13. , , , , , . Mother-to-child transmission of toxoplasmosis: Risk estimates for clinical counselling. Lancet. 1999;353(9167):1829-33.
    [CrossRef] [PubMed] [Google Scholar]
  14. , , , , , , et al. Toxoplasma serology in Zambian and Ugandan patients infected with the human immunodeficiency virus. Trans R Soc Trop Med Hyg. 1991;85(2):227-9.
    [CrossRef] [PubMed] [Google Scholar]
  15. , , . Sero-prevalence of Toxoplasma gondii infection in humans in Khartoum State, Sudan. Int J Trop Med. 2012;7(4):143-50.
    [CrossRef] [Google Scholar]
  16. , , . Latent Toxoplasma gondii infection and associated risk factors among HIV-infected individuals at Arba Minch hospital, South Ethiopia. AIDS Res Treat. 2014;2014:652941.
    [CrossRef] [PubMed] [Google Scholar]
  17. , , . High sero-prevalence of specific Toxoplasma gondii IgG antibodies among HIV/AIDS patients with immunological failure attending a tertiary hospital in North-Western Tanzania. Tanzan J Health Res. 2016;18(1):1-4.
    [Google Scholar]
  18. , , , . Incidence and risk factors of toxoplasmosis in a cohort of human immunodeficiency virus-infected patients: 1988-1995, HEMOCO and SEROCO Study Groups. Clin Infect. 1999;28(3):575-81.
    [CrossRef] [PubMed] [Google Scholar]
  19. , , , , . Prevalence of antibodies against Toxoplasma gondii in patients infected with human immunodeficiency virus in Croatia. Infektol Glasnik. 2010;30(1):5-10.
    [Google Scholar]
  20. , , , , , , et al. Clinico-epidemiological characteristics of HIV positive immigrants: Study of 371 cases. Enferm Infect Microbiol Clin. 2012;30(8):441-51.
    [CrossRef] [PubMed] [Google Scholar]
  21. , , , , , , et al. Seroprevalence of anti-Toxoplasma IgG antibody in Japanese patients with HIV infection. Kansenshogaku Zasshi. 2001;75(8):703-4.
    [CrossRef] [PubMed] [Google Scholar]
  22. , , , , . Frequency of Toxoplasma gondii in HIV positive patients from west of Iran by ELISA and PCR. Iran J Parasitol. 2014;9(4):474-81.
    [PubMed] [Google Scholar]
  23. , , , , , , et al. High sero-prevalence of Toxoplasma gondii antibody in HIV/AIDS individuals from north of Iran. Iran J Parasitol. 2015;10(4):584-9.
    [PubMed] [Google Scholar]
  24. , . Seroprevalence of cytomegalovirus, Toxoplasma gondii syphilis, and hepatitis B and C virus infections in a regional population seropositive for HIV infection. Can J Infect Dis. 1998;9(4):209-14.
    [CrossRef] [PubMed] [Google Scholar]
  25. , , , , , , et al. Prevalence and predictors of Toxoplasma seropositivity in women with and at risk for human immunodeficiency virus infection. Clin Infect Dis. 2002;35(11):1414-7.
    [CrossRef] [PubMed] [Google Scholar]
  26. , , , , , . Toxoplasma gondii seroprevalence: 30-year trend in an HIV-infected US military cohort. Diagn Microbiol Infect Dis. 2016;84(1):34-5.
    [CrossRef] [PubMed] [Google Scholar]
  27. , , , , , , et al. Hepatitis B, C, Treponema pallidum and Toxoplasma gondii co-infections in HIV infected patients. Rev Med Chil. 2009;137(5):641-8.
    [CrossRef] [PubMed] [Google Scholar]
  28. , , , , , . Importance of high IgG anti-Toxoplasma gondii titers and PCR detection of T. gondii DNA in peripheral blood samples for the diagnosis of AIDS-related cerebral toxoplasmosis: A case-control study. Braz J Infect. 2011;15(4):356-9.
    [CrossRef] [PubMed] [Google Scholar]
  29. , , , . Evaluation of seroepidemiological toxoplasmosis in HIV/ AIDS patients in the south of Brazil. Rev Inst Med Trop Sao Paulo. 2013;55(1):25-30.
    [CrossRef] [PubMed] [Google Scholar]
  30. , , , , , , et al. Seroepidemiology of Toxoplasma gondii infection in patients with liver disease in eastern China. Epidemiol Infect. 2017;145(11):2296-302.
    [CrossRef] [PubMed] [Google Scholar]
  31. , , . Seroprevalence of toxoplasmosis in high school girls in Fasa district, Iran. Iran J Immunol. 2005;2(3):177-81.
    [Google Scholar]
  32. , , . The epidemiology of Toxoplasma infection In: , , eds. Toxoplasmosis: A Comprehensive Clinical Guide. Cambridge: Cambridge University Press; . p. :58-124.
    [CrossRef] [Google Scholar]
  33. , , , . Seroprevalence of Toxoplasma gondii antibodies amongst pregnant women attending antenatal clinic of Federal Medical Center, Lagos, Nigeria. Niger Postgrad Med J. 2011;2(4):1135-9.
    [PubMed] [Google Scholar]
  34. , , , , , , et al. Seroprevalence of Toxoplasma gondii Antibodies amongst Pregnant Women at the Lagos State University Teaching Hospital, Nigeria. Niger Postgrad Med J. 2010;17(2):164-7.
    [CrossRef] [PubMed] [Google Scholar]
  35. , , , , . Seroprevalence and risk factors for Toxoplasma gondii infection among antenatal women in Zaria, Nigeria. Res J Med Med Sci. 2009;4(2):483-8.
    [Google Scholar]
  36. , , . Toxoplasmosis snapshots: Global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol. 2009;39(12):1385-94.
    [CrossRef] [PubMed] [Google Scholar]
  37. , , . Toxoplasmosis: A global infection, so widespread, so neglected. Int J Sci Res Publ. 2013;3:23-8.
    [Google Scholar]
  38. , , , . Toxoplasmosis-a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries. PLoS. 2014;9(3):e90203.
    [CrossRef] [PubMed] [Google Scholar]
  39. , . Toxoplasmosis in Nigeria: The story so far (19502016) A review. Folia Parasitol (Praha). 2016;63:2016.030.
    [CrossRef] [PubMed] [Google Scholar]
  40. , . Seroprevalence and associated risk factors of toxoplasmosis in pregnant women in Hebron district, Palestine. East Mediterr Health J. 2009;15(5):1279-84.
    [PubMed] [Google Scholar]
  41. , , , . Seroprevalence of Toxoplasma gondii infection in HIV-positive and HIV-negative subjects in Gauteng, South Africa. S Afr J Epidemiol Infect. 2011;26(4):225-8.
    [CrossRef] [Google Scholar]
  42. , , , , , . Seroepidemiology of Toxoplasma gondii infection in women with first trimester spontaneous miscarriage in Qena Governorate, Egypt. J Clin Diagn Res. 2013;7(12):2870-3.
    [CrossRef] [PubMed] [Google Scholar]
  43. , , , , , . Seroprevalence of and risk factors for Toxoplasma gondii antibodies among asymptomatic blood donors in Egypt. Parasitol Res. 2009;104(6):1471-6.
    [CrossRef] [PubMed] [Google Scholar]
  44. , , , , , . Seroepidemiology of Toxoplasma gondii infection in general population in a Northern Mexican city. J Parasitol. 2011;97(1):40-3.
    [CrossRef] [PubMed] [Google Scholar]
  45. , , . Toxoplasmosis needs evaluation. An overview and proposals. Am J Dis. 1989;143(6):724-8.
    [CrossRef] [PubMed] [Google Scholar]
  46. , , , , . Detection of genomic Toxoplasma gondii DNA and anti-Toxoplasma antibodies in high risk women and contact animals. Glob Vet. 2009;3(5):395-400.
    [Google Scholar]
  47. , , , , . Anti-Toxoplasma antibody prevalence, primary infection rate, and risk factors in a study of toxoplasmosis in 4, 466 pregnant women in Japan. Clin Vaccine Immunol. 2011;19(3):365-7.
    [CrossRef] [PubMed] [Google Scholar]
  48. , , . Seroprevalence of Toxoplasma gondii infection and associated risk factors among pregnant women in Debre Tabor, Northwest Ethiopia. BMC Res Notes. 2015;8:107.
    [CrossRef] [PubMed] [Google Scholar]
  49. , , , , , , et al. Seroprevalence and factors associated with Toxoplasma gondii infection among pregnant women attending antenatal care in the referral hospital in Tanzania: Cross sectional study. Ann Clin Lab Res. 2015;3(2):17-22.
    [CrossRef] [Google Scholar]
  50. , , , , , . Seroprevalence of Toxoplasma gondii and associated risk factors among pregnant women in Jimma town, Southwestern Ethiopia. BMC Infect Dis. 2012;12:337.
    [CrossRef] [PubMed] [Google Scholar]
  51. , , , , , , et al. Seroepidemiology of Toxoplasma gondii infection in women of child-bearing age in central Ethiopia. BMC Infect Dis. 2013;13:101.
    [CrossRef] [PubMed] [Google Scholar]
  52. , , . High prevalence of anti-Toxoplasma antibodies and absence of Toxoplasma gondii risk factors among pregnant women attending routine antenatal care in two hospitals of Addis Ababa, Ethiopia. Int J Infect Dis. 2015;34:41-5.
    [CrossRef] [PubMed] [Google Scholar]
  53. , , , , , . Prevalence of congenital toxoplasmosis in pregnant women with complicated pregnancy outcomes in Assiut governorate, Egypt. J Adv Parasitol. 2017;4(1):1-8.
    [CrossRef] [Google Scholar]
  54. , . Cats and Toxoplasma Implications for public health. Zoonoses Public Health. 2010;57(1):34-52.
    [CrossRef] [PubMed] [Google Scholar]
  55. , , , , , . Seroprevalence and sources of Toxoplasma infection among indigenous and immigrant pregnant women in Taiwan. Parasitol Res. 2008;103(1):67-74.
    [CrossRef] [PubMed] [Google Scholar]
  56. , , . Seroprevalence of toxoplasmosis among pregnant women in Osogbo, Southwestern, Nigeria. J Infect Dis Immun. 2018;10(2):8-16.
    [Google Scholar]
  57. , , , , , , et al. Toxoplasma gondii antibodies in pregnant women and their Newborns in Dar es Salaam, Tanzania. Am J Trop Med Hyg. 1995;52(6):546-8.
    [CrossRef] [PubMed] [Google Scholar]
  58. , , , , , . Toxoplasma gondii The effects of infection at different stages of pregnancy on the offspring of mice. Exp Parasitol. 2011;127(1):107-12.
    [CrossRef] [PubMed] [Google Scholar]
  59. , , , , . A possible relationship between Toxoplasma gondii and Schizophrenia: A seroprevalence study. Int J Psychiatry Clin Pract. 2009;13(1):82-7.
    [CrossRef] [PubMed] [Google Scholar]
Show Sections